[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-349986-105":59,"doc-detail-349986-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","crispr-screen-of-human-pancreatic-cancer-xenografts-identifies-a-klf5-proliferation-vulnerability-through-epigenetic-modifiers-ncapd2-and-mthfd1","CRISPR screen of human pancreatic cancer xenografts identifies a KLF5 proliferation vulnerability through epigenetic modifiers NCAPD2 and MTHFD1","","Cancer metastases that cause death often lack additional driver mutations beyond the primary tumor. Building on prior findings of heterochromatin loss in metastatic-seeding cells in pancreatic tumors, this study tests whether chromatin alterations create vulnerabilities in distant metastases. Using CRISPR screens in patient-derived xenografts, KLF5 is essential for metastatic proliferation, inducing epigenetic modifier genes NCAPD2 and MTHFD1 that support migration and epithelial-mesenchymal transition programs.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/crispr-screen-of-human-pancreatic-cancer-xenografts-identifies-a-klf5-proliferation-vulnerability-through-epigenetic-modifiers-ncapd2-and-mthfd1/349986/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/crispr-screen-of-human-pancreatic-cancer-xenografts-identifies-a-klf5-proliferation-vulnerability-through-epigenetic-modifiers-ncapd2-and-mthfd1/349986.png","ImageObject",300,407,{"name":92,"@type":93},"Margaret","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":19},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What central problem does the study address in pancreatic cancer metastasis?","Question",{"text":112,"@type":113},"It addresses why lethal distant metastases usually do not show metastasis-specific driver mutations beyond those in the primary pancreatic tumors.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What does the CRISPR screen identify as essential for metastatic growth?",{"text":117,"@type":113},"The screen identifies KLF5 as essential for metastatic cell proliferation while not being required for primary tumor growth.",{"name":119,"@type":110,"acceptedAnswer":120},"How do NCAPD2 and MTHFD1 relate to KLF5 in driving metastasis-related programs?",{"text":121,"@type":113},"KLF5 induces epigenetic modifier genes, including NCAPD2 and MTHFD1, which facilitate expression of genes involved in migration and epithelial-mesenchymal transition.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},349986,1790160001,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":19,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},137451207643,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","Maeda et al. Molecular Cancer (2026) 25:75 Molecular Cancer  \n[https://doi.org/10.1186/s12943-026-02575-z](https://doi.org/10.1186/s12943-026-02575-z)  \nRESEARCH Open Access  \nCRISPR screen of human pancreatic cancer xenografts identifies a KLF5 proliferation vulnerability through epigenetic modifiers NCAPD2 and MTHFD1  \nMasahiro Maeda1,2,13†, Kenna Sherman1,3†, Weiqiang Zhou4†, Jiaqi Cheng4, Yuta Nihongaki5, Adrian Idrizi 1,2, RakelTryggvadottir1,2, Oscar Camacho1, Xingbo Shang6, Jimin Min7, Michael A. Koldobskiy 1,8, Anirban Maitra7,9, Andre Levchenko6, Barbara S. Slusher 10, Hongkai Ji4 and Andrew P. Feinberg 1,2,11,12*  \nAbstract  \nOne of the major conundrums of cancer research and treatment is that the metastases that lead to death inmost patients do not appear to involve additional driver mutations. Previously, we reported widespread loss of heterochromatin with activation of pro-metastatic genes in the subset of cells of primary pancreatic tumors that gave rise to liver and lung metastases. Here we hypothesized that this change in chromatin could create unique vulnerabilities in distant metastases. Using a CRISPR screen of human patient-derived xenografts from metastases and primary tumors, we identified KLF5 as essential for metastatic cell proliferation but not primary tumor growth. Further, we found that KLF5 induced epigenetic modifier genes, including NCAPD2 and MTHFD1, which themselves facilitated expression of specific genes driving migration and epithelial-mesenchymal transition, including TGFBR2, VIM, EMP1, and ITGB1 . Inhibition of expression of these modifier genes restored heterochromatin in the specific regions that distinguish the primary and metastatic tumors. We backed up this causal chain of evidence with rigorous additional knockdown experiments with the modifier genes, and single cell RNA and chromatin experiments, and we also replicated the main findings in a second set of paired primary and distant metastasis xenograft lines. Finally, KLF5 expression was strongly associated with patient survival and human PDAC cell plasticity in a dataset of 70 PDAC patients and KLF5 expression was increased in the majority of lung, liver and peritoneal metastases compared to the matched primary tumor, confirming its importance in PDAC metastasis and mortality. In summary, we have identified a cascade of epigenetic modulators, modifiers and mediators that maintains the widespread heterochromatin loss supporting metastatic cell proliferation in human pancreatic cancer (see Graphical Abstract) .  \n†Masahiro Maeda, Kenna Sherman and Weiqiang Zhou contributed equally to this work.  \n*Correspondence: Andrew P. Feinberg [afeinberg@jhu.edu](afeinberg@jhu.edu)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/licenses/by-nc-nd/4.0/](vecommons.org/licenses/by-nc-nd/4.0/.)[.](vecommons.org/licenses/by-nc-nd/4.0/.)  \nMaeda et al. Molecular Cancer (2026) 25:75 Page 2 of 22  \n\n| Graphi","cbCaiinPwjbuK9cN","https://ap.wps.com/l/cbCaiinPwjbuK9cN","pdf",7359759,22,"English","# Abstract\n# Introduction","[{\"question\":\"What central problem does the study address in pancreatic cancer metastasis?\",\"answer\":\"It addresses why lethal distant metastases usually do not show metastasis-specific driver mutations beyond those in the primary pancreatic tumors.\"},{\"question\":\"What does the CRISPR screen identify as essential for metastatic growth?\",\"answer\":\"The screen identifies KLF5 as essential for metastatic cell proliferation while not being required for primary tumor growth.\"},{\"question\":\"How do NCAPD2 and MTHFD1 relate to KLF5 in driving metastasis-related programs?\",\"answer\":\"KLF5 induces epigenetic modifier genes, including NCAPD2 and MTHFD1, which facilitate expression of genes involved in migration and epithelial-mesenchymal transition.\"}]","CRISPR screen of human pancreatic cancer xenografts identifies a KLF5 proliferation vulnerability through epigenetic modifiers NCAPD2 and MTHFD1 | PDF",1790086599,55,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6ed43896c822dfdf491792068c39795b.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/31c1a806ceb52930d649373dd1151eee.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d896b2925299b9bfd2ffb388f1e3474e.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/04e9e83b2d40412b921e6997b986bbe7.webp",980,1306]